Stay updated with breaking news from Morphic Holding. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of Morphic Holding, Inc. (NASDAQ:MORF – Get Rating) hit a new 52-week high during trading on Tuesday after BMO Capital Markets raised their price target on the stock from $83.00 to $106.00. The company traded as high as $54.97 and last traded at $52.72, with a volume of 1898374 shares trading hands. The stock […]
Morphic Holding, Inc. (NASDAQ:MORF – Get Rating) shares saw unusually-high trading volume on Wednesday after BMO Capital Markets raised their price target on the stock from $83.00 to $106.00. Approximately 276,985 shares traded hands during trading, a decline of 37% from the previous session’s volume of 439,045 shares.The stock last traded at $49.53 and had […]
WALTHAM, Mass., April 24, 2023 -- Morphic Therapeutic , a biopharmaceutical company developing a new generation of oral integrin therapies for the treatment of serious chronic diseases, today... | April 24, 2023
In the first quarter of this year, total healthcare and life sciences M&A in the U.S. was about $71 billion, according to KPMG.
Morphic Holding, Inc. (NASDAQ:MORF – Get Rating) CAO Robert E. Farrell, Jr. sold 20,000 shares of the firm’s stock in a transaction dated Monday, April 17th. The shares were sold at an average price of $41.25, for a total transaction of $825,000.00. Following the sale, the chief accounting officer now owns 2,222 shares of the […]